Nuwellis receives US patent for hemolysis sensor technology in blood filtration
PositiveFinancial Markets

Nuwellis has been granted a US patent for its innovative hemolysis sensor technology, which is set to enhance blood filtration processes. This advancement is significant as it promises to improve patient safety and treatment outcomes by accurately detecting hemolysis, a condition that can lead to serious complications. The patent not only validates Nuwellis's commitment to innovation in medical technology but also positions the company as a leader in the field, potentially paving the way for new applications and partnerships.
— Curated by the World Pulse Now AI Editorial System